4basebio PLC (4BB) To Supply opDNA for Client’s Phase I; TriLink Named CDMO

4basebio will supply clinical—grade opDNA starting material for a multi—national pharma client’s Phase I cell therapy program, with TriLink BioTechnologies selected as CDMO to manufacture the mRNA drug substance using CleanCap.Material DetailsContext by AI AnalystThis extends 4basebio’s push to rep…